TARA WAGNER: Open Payments
NPI 1750099008 · CYNTHIANA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 51 payments from 22 companies in 2025. Trend: 2023 $351 · 2024 $1,161 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $210 |
| Novo Nordisk Inc | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Corcept Therapeutics | 3 | $64 |
| GlaxoSmithKline, LLC. | 2 | $60 |
| Insulet Corporation | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Exact Sciences Corporation | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
Products named: UBRELVY, VRAYLAR, LEQVIO, Korlym, TRELEGY ELLIPTA, Omnipod, QULIPTA, CAPLYTA.
Industry payments across KY — which companies pay providers there.
